UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HIV reservoirs and latency models

Virology (New York, N.Y.), 2011-03, Vol.411 (2), p.344-354

2011

Volltextzugriff (PDF)

Single-cell RNA sequencing reveals common and unique gene expression profiles in primary CD4+ T cells latently infected with HIV under different conditions

Frontiers in cellular and infection microbiology, 2023-12, Vol.13, p.1286168-1286168

2023

Volltextzugriff (PDF)

Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation

Bioorganic & medicinal chemistry letters, 2020-07, Vol.30 (13), p.127197-127197, Article 127197

2020

Volltextzugriff (PDF)

Selective miRNA Modulation Fails to Activate HIV Replication in In Vitro Latency Models

Molecular therapy. Nucleic acids, 2019-09, Vol.17, p.323-336

2019

Volltextzugriff (PDF)

Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV

Cell host & microbe, 2018-01, Vol.23 (1), p.14-26

2018

Volltextzugriff (PDF)

HIV “shock and kill” therapy: In need of revision

Antiviral research, 2019-06, Vol.166, p.19-34

2019

Volltextzugriff (PDF)

Post-treatment control of HIV infection

Proceedings of the National Academy of Sciences - PNAS, 2015-04, Vol.112 (17), p.5467-5472

2015

Volltextzugriff (PDF)

The mTOR Complex Controls HIV Latency

Cell host & microbe, 2016-12, Vol.20 (6), p.785-797

2016

Volltextzugriff (PDF)

CD8+ T cells promote HIV latency by remodeling CD4+ T cell metabolism to enhance their survival, quiescence, and stemness

Immunity (Cambridge, Mass.), 2023-05, Vol.56 (5), p.1132-1147.e6

2023

Volltextzugriff (PDF)

Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform

Cell, 2019-10, Vol.179 (4), p.880-894.e10

2019

Volltextzugriff (PDF)

Unique natural and adaptive response mechanisms to control and eradicate HIV infection

AIMS allergy and immunology, 2018-01, Vol.2 (3), p.113-125

Amsterdam, Daniel

2018

Volltextzugriff (PDF)

P-TEFb as a target to reactivate latent HIV: Two Brds are now in hand

Cell cycle (Georgetown, Tex.), 2013-02, Vol.12 (3), p.392-393

Rice, Andrew P.

2013

Volltextzugriff (PDF)

Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat

The Journal of infectious diseases, 2022-03, Vol.225 (5), p.856-861

2022

Volltextzugriff (PDF)

Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e1973-e1981

2021

Volltextzugriff (PDF)

Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents?

Current opinion in HIV & AIDS, 2016-07, Vol.11 (4), p.394-401

2016

Volltextzugriff (PDF)

The impact of immune checkpoint therapy on the latent reservoir in HIV infected individuals with cancer on antiretroviral therapy

AIDS (London), 2021-08, Vol.35 (10), p.1631-1636

2021

Volltextzugriff (PDF)

Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy

AIDS (London), 2016-06, Vol.30 (9), p.1385-1392

2016

Volltextzugriff (PDF)

A latency fractional order model for HIV dynamics

Journal of computational and applied mathematics, 2017-03, Vol.312, p.240-256

2017

Volltextzugriff (PDF)

Immediate antiviral therapy appears to restrict resting CD4⁺ cell HIV-1 infection without accelerating the decay of latent infection

Proceedings of the National Academy of Sciences - PNAS, 2012-06, Vol.109 (24), p.9523-9528

2012

Volltextzugriff (PDF)

The combination of venetoclax and ixazomib selectively and efficiently kills HIV infected cell lines, but has unacceptable toxicity in primary cell models

Journal of virology, 2021-05, Vol.95 (12)

2021

Volltextzugriff (PDF)

Transcriptional control of HIV latency: Cellular signaling pathways, epigenetics, happenstance and the hope for a cure

Virology (New York, N.Y.), 2014-04, Vol.454, p.328-339

2014

Volltextzugriff (PDF)

Monocyte to macrophage differentiation and changes in cellular redox homeostasis promote cell type-specific HIV latency reactivation

Proceedings of the National Academy of Sciences - PNAS, 2024-05, Vol.121 (19), p.e2313823121

2024

Volltextzugriff (PDF)

HIV-1-Infected CD4+ T Cells Facilitate Latent Infection of Resting CD4+ T Cells through Cell-Cell Contact

Cell reports (Cambridge), 2018-08, Vol.24 (8), p.2088-2100

2018

Volltextzugriff (PDF)

1 – 25 von 2.798

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.621)
Mit Volltextzugriff
(2.338)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.475)
Humans
(2.242)
Life Sciences & Biomedicine
(2.166)
Hiv
(1.455)
Human Immunodeficiency Virus
(1.272)
Virus Latency
(1.129)
Latency
(1.045)
Virology
(1.011)
Hiv-1 - Physiology
(900)
Hiv Infections - Virology
(898)
Hiv Infections - Drug Therapy
(767)
Immunology
(746)
Infectious Diseases
(620)
Hiv-1 - Genetics
(588)
Cd4-Positive T-Lymphocytes - Virology
(576)
Infections
(553)
Aids/hiv
(540)
Lymphocytes
(472)
Microbiology
(468)
Hiv-1
(467)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(2.394)
Open access e-journals list
(1.914)
Ingenta
(1.535)
IngentaConnect Journals
(1.090)
Journals@Ovid Ovid Full Text
(749)
Publisher or Other Site
(532)
Elsevier ScienceDirect Journals Complete
(358)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(301)
SpringerLink
(264)
Springer Nature - Connect here FIRST to enable access
(203)
Nexis Uni (LexisNexis)
(200)
Wiley-Blackwell Journals
(172)
JSTOR
(163)
Oxford Journals
(123)
Wiley Online Library
(116)
Oxford Journals 2020 Medicine
(95)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(92)
Taylor & Francis Journals Auto-Holdings Collection
(84)
Taylor & Francis
(67)
Taylor & Francis Journals Complete
(50)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Virology
(163)
Aids
(116)
Viruses
(113)
Plos Pathogens
(106)
Plos One
(97)
Retrovirology
(87)
The Journal Of Infectious Diseases
(63)
Aids Research And Human Retroviruses
(59)
Virology
(59)
Scientific Reports
(58)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

HIV reservoirs and latency models

Single-cell RNA sequencing reveals common and unique gene expression profiles in primary CD4+ T cells latently infected with HIV under different conditions

Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation

Selective miRNA Modulation Fails to Activate HIV Replication in In Vitro Latency Models

Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV

Intact HIV reservoir estimated by the intact proviral DNA assay correlates with levels of total and integrated DNA in the blood during suppressive antiretroviral therapy

HIV “shock and kill” therapy: In need of revision

Post-treatment control of HIV infection

The mTOR Complex Controls HIV Latency

CD8+ T cells promote HIV latency by remodeling CD4+ T cell metabolism to enhance their survival, quiescence, and stemness

Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform

Unique natural and adaptive response mechanisms to control and eradicate HIV infection

P-TEFb as a target to reactivate latent HIV: Two Brds are now in hand

Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat

Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study

Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents?

The impact of immune checkpoint therapy on the latent reservoir in HIV infected individuals with cancer on antiretroviral therapy

Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy

A latency fractional order model for HIV dynamics

Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy

Immediate antiviral therapy appears to restrict resting CD4⁺ cell HIV-1 infection without accelerating the decay of latent infection

The combination of venetoclax and ixazomib selectively and efficiently kills HIV infected cell lines, but has unacceptable toxicity in primary cell models

Transcriptional control of HIV latency: Cellular signaling pathways, epigenetics, happenstance and the hope for a cure

Monocyte to macrophage differentiation and changes in cellular redox homeostasis promote cell type-specific HIV latency reactivation

HIV-1-Infected CD4+ T Cells Facilitate Latent Infection of Resting CD4+ T Cells through Cell-Cell Contact

Suchergebnisse filtern